Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP826138.RAOGJ1bQvoHQ8vKhpH01cQrFAuic9VxVB1ah-cFwXRD7A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP826138.RAOGJ1bQvoHQ8vKhpH01cQrFAuic9VxVB1ah-cFwXRD7A130_assertion type Assertion NP826138.RAOGJ1bQvoHQ8vKhpH01cQrFAuic9VxVB1ah-cFwXRD7A130_head.
- NP826138.RAOGJ1bQvoHQ8vKhpH01cQrFAuic9VxVB1ah-cFwXRD7A130_assertion description "[Gains of 1p34-36, 6p21, 9q34, 17q25, and 20q and losses of 1p11-p31, 2q32-33, 4q11-13, 6q21, and 13q21-31 may represent secondary events in progression, as they were only detected in poorly differentiated and anaplastic carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP826138.RAOGJ1bQvoHQ8vKhpH01cQrFAuic9VxVB1ah-cFwXRD7A130_provenance.
- NP826138.RAOGJ1bQvoHQ8vKhpH01cQrFAuic9VxVB1ah-cFwXRD7A130_assertion evidence source_evidence_literature NP826138.RAOGJ1bQvoHQ8vKhpH01cQrFAuic9VxVB1ah-cFwXRD7A130_provenance.
- NP826138.RAOGJ1bQvoHQ8vKhpH01cQrFAuic9VxVB1ah-cFwXRD7A130_assertion SIO_000772 12414503 NP826138.RAOGJ1bQvoHQ8vKhpH01cQrFAuic9VxVB1ah-cFwXRD7A130_provenance.
- NP826138.RAOGJ1bQvoHQ8vKhpH01cQrFAuic9VxVB1ah-cFwXRD7A130_assertion wasDerivedFrom befree-20140225 NP826138.RAOGJ1bQvoHQ8vKhpH01cQrFAuic9VxVB1ah-cFwXRD7A130_provenance.
- NP826138.RAOGJ1bQvoHQ8vKhpH01cQrFAuic9VxVB1ah-cFwXRD7A130_assertion wasGeneratedBy ECO_0000203 NP826138.RAOGJ1bQvoHQ8vKhpH01cQrFAuic9VxVB1ah-cFwXRD7A130_provenance.